Phenelzine-Induced Fulminant Hepatic Failure

  title={Phenelzine-Induced Fulminant Hepatic Failure},
  author={E. G{\'o}mez-Gil and J. Salmer{\'o}n and A. Mas},
  journal={Annals of Internal Medicine},
TO THE EDITOR: During the last year, two of our patients who had received phenelzine (a monoamine oxidase inhibitor commonly used to treat depression and other psychiatric and nonpsychiatric disorders) for 4 months (22.5 mg and 60 mg twice daily, respectively) had emergency orthotopic liver transplantation because of fulminant hepatic failure [1]. Phenelzine-induced fulminant hepatic failure was diagnosed after adequate biochemical, serologic, immunologic, hematologic, and histologic studies… Expand
16 Citations
Antidepressant-induced liver injury: a review for clinicians.
  • 111
  • PDF
Mining hidden knowledge for drug safety assessment: topic modeling of LiverTox as a case study
  • 12
An update on amine oxidase inhibitors: Multifaceted drugs
  • 63
  • PDF
Advances Pertaining to the Pharmacology and Interactions of Irreversible Nonselective Monoamine Oxidase Inhibitors
  • P. K. Gillman
  • Chemistry, Medicine
  • Journal of clinical psychopharmacology
  • 2011
  • 44
  • PDF
MAO inhibitors: Risks, benefits, and lore
  • 74
  • PDF
Children and adolescents